首页 > 市场调查报告书 > 食物/饮料

食品添加剂机能性食品

市场调查报告书

商品编码

1547597

全球 CROCIN 市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global CROCIN Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球藏红花素市场需求将从 2023 年的 53.6 亿美元达到近 88.1 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.66%。

藏红花素是一种基于扑热息痛的镇痛剂和解热剂，用作止痛剂，可提供快速有效的暂时缓解。它也用于快速有效地缓解感冒、流感症状和发烧。藏红花素有针对性地缓解疼痛，可用于治疗头痛、偏头痛、月经痛、关节炎、牙痛和肌肉骨骼疼痛。该药物含有经临床证明的成分，如扑热息痛和咖啡因。它透过阻止引起疼痛和发烧的化学信使的释放来作用于疼痛的中心。成人及12岁以上儿童均可使用。对于患有心血管疾病/心臟病、高血压、胃敏感和糖尿病患者来说，它被认为是安全的。藏红花呈颜色的藏红花素是一种类胡萝卜素化合物，存在于藏红花和栀子花等花朵中。

市场动态

生活方式的改变、由于压力增加而导致的不同类型疼痛的盛行率增加，特别是在城市人口中，将是市场成长的主要刺激因素。藏红花素既可以作为镇痛剂，也可以作为解热剂，完全缓解疼痛和发烧，这将进一步推动市场成长。藏红花素在康復计划中被证明对人们的心理健康状况有益，这将使市场受益。该药物的推广和广告方面的大量投资将有利于市场成长。提供广泛的产品来满足所有年龄层消费者的需求将是市场的助推器。替代品的可用性以及全球一小部分人口报告的副作用将阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对 CROCIN 全球市场的每个细分市场进行了包容性评估。藏红花素产业的成长和趋势为本研究提供了整体方法。

市场区隔

CROCIN 市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按申请

食物
化工
药物
其他的

按纯度

纯度>98%
纯度<98%

按指示

疼痛
发热（发烧）

按配销通路

医院药房
零售药房
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲地区对番红花市场的当前和未来需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 CROCIN 市场的主要参与者包括 TCI Chemicals Pvt.。 Ltd.、Merck KGaA、GSK Plc.、Cayman Chemical、APExBIO Technology、Wilshire Technologies、Biosynth、Cipla Inc.、Novartis AG、Sanofi、Aurobindo Pharma、Teva Pharmaceutical Industries Ltd.、Mallinckrodt。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 市场吸引力分析：依应用分类
- 按纯度分析市场吸引力
- 按指标进行的市场吸引力分析
- 按配销通路分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球藏红花素市场分析：依应用分类

概述：按应用
历史和预测数据
分析：按应用
食物
化工
药物
其他的

第 6 章：全球藏红花素市场分析：依纯度

纯度概述
历史和预测数据
纯度分析
纯度>98%
纯度<98% 按地区分類的历史和预测销售额

第 7 章：全球藏红花素市场分析：依适应症分类

按指示概述
历史和预测数据
按指标分析
疼痛
发热（发烧）

第 8 章：全球藏红花素市场分析：按分销管道

配销通路概览
历史和预测数据
按配销通路分析
医院药房
零售药房
其他的

第 9 章：全球藏红花素市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：Crocin 公司的竞争格局

藏红花市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
TCI Chemicals Pvt. Ltd.

公司概况
公司收入
产品
最新动态

Merck KGaA

公司概况
公司收入
产品
最新动态

GSK Plc.

公司概况
公司收入
产品
最新动态

Cayman Chemical

公司概况
公司收入
产品
最新动态

APExBIO Technology

公司概况
公司收入
产品
最新动态

Wilshire Technologies

公司概况
公司收入
产品
最新动态

Biosynth

公司概况
公司收入
产品
最新动态

Cipla Inc.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

Aurobindo Pharma

公司概况
公司收入
产品
最新动态

Teva Pharmaceutical Industries Ltd.

公司概况
公司收入
产品
最新动态

Mallinckrodt

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214564

The global demand for CROCIN Market is presumed to reach the market size of nearly USD 8.81 Billion by 2032 from USD 5.36 Billion in 2023 with a CAGR of 5.66% under the study period 2024-2032.

Crocin is a paracetamol-based analgesic and antipyretic used as a pain killer to provide fast and effective temporary relief. It is also used for rapid and effective relief from cold & flu symptoms and fever. Crocin offers targeted pain relief and can be used for headaches, migraines, menstrual pain, arthritis, toothache, and musculoskeletal pain. The medication contains clinically proven ingredients like paracetamol and caffeine. It acts at the center of pain by blocking the release of pain and fever-causing chemical messengers. It can be used by adults & children over 12 years. It is considered safe for people with CVD/heart conditions, high blood pressure, sensitive stomach, and diabetics. Crocin responsible for the color of saffron is a carotenoid chemical compound present in the flowers like crocus and gardenia.

MARKET DYNAMICS

Changing lifestyles, increased prevalence of pains of different types due to rising stress, especially among the urban population, will be the main stimulating factors for market growth. Crocin serving both as an analgesic and antipyretic to provide total relief from pain and fever will further propel market growth. Crocin, proven to have beneficial effects on people's mental health status in rehabilitation programs, will benefit the market. Heavy investments in promoting and advertising the drug will favor market growth. Availability of a wide range of products to address consumers' needs of all age groups will be a market booster. Availability of alternatives and the side effects reported by a small portion of the global population will hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of CROCIN. The growth and trends of CROCIN industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the CROCIN market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Food
Chemical Industry
Drug
Others

By Purity

Purity >98%
Purity <98%

By Indication

Pain
Pyrexia (Fever)

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the CROCIN market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the CROCIN market include TCI Chemicals Pvt. Ltd., Merck KGaA, GSK Plc., Cayman Chemical, APExBIO Technology, Wilshire Technologies, Biosynth, Cipla Inc., Novartis AG, Sanofi, Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Mallinckrodt. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CROCIN - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Purity
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CROCIN MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Food Historic and Forecast Sales By Regions
5.5. Chemical Industry Historic and Forecast Sales By Regions
5.6. Drug Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL CROCIN MARKET ANALYSIS BY PURITY

6.1. Overview By Purity
6.2. Historical and Forecast Data
6.3. Analysis By Purity
6.4. Purity >98% Historic and Forecast Sales By Regions
6.5. Purity <98% Historic and Forecast Sales By Regions

7. GLOBAL CROCIN MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Pain Historic and Forecast Sales By Regions
7.5. Pyrexia (Fever) Historic and Forecast Sales By Regions

8. GLOBAL CROCIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data
8.3. Analysis By Distribution Channel
8.4. Hospital Pharmacy Historic and Forecast Sales By Regions
8.5. Retail Pharmacy Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL CROCIN MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CROCIN COMPANIES

10.1. CROCIN Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CROCIN INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. TCI Chemicals Pvt. Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GSK Plc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Cayman Chemical
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. APExBIO Technology
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Wilshire Technologies
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Biosynth
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cipla Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Novartis AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sanofi
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Aurobindo Pharma
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Teva Pharmaceutical Industries Ltd.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Mallinckrodt
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments